Article info
Clinical and epidemiological research
Extended report
Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study
- Correspondence to Dr Filip Van den Bosch, Department of Rheumatology, Ghent University Hospital, Building 1P6, De Pintelaan 185, Gent 9000, Belgium; Filip.Vandenbosch{at}ugent.be
Citation
Anti-TNF-induced remission in very early peripheral spondyloarthritis: the CRESPA study
Publication history
- Received November 4, 2016
- Revised January 16, 2017
- Accepted January 22, 2017
- First published February 17, 2017.
Online issue publication
October 31, 2019
Article Versions
- Previous version (11 July 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/